on 25 Dec 2018
Last Applicant/ Owned by
The Maynard Centre,
GB
Serial Number
79223494 filed on 24th Jul 2017
Registration Number
5634962 registered on 25th Dec 2018
Correspondent Address
Melanie Howard
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Medical and veterinary devices, namely, instruments for the preparation of regenerative cells for implantation into humans and animals for the treatment of damaged and diseased skin, tissue, organs and body parts; disposable cartridges for medical and veterinary devices, namely, instruments for the preparation of regenerative cells for implantation into humans and animals for the treatment of damaRead More
Medical and veterinary devices, namely, instruments for the preparation of regenerative cells for implantation into humans and animals for the treatment of damaged and diseased skin, tissue, organs and body parts; disposable cartridges for medical and veterinary devices, namely, instruments for the preparation of regenerative cells for implantation into humans and animals for the treatment of damaged and diseased skin, tissue, organs and body parts; portable medical and veterinary apparatus, namely, instruments for the preparation of regenerative cells for implantation into humans and animals for the treatment of damaged and diseased skin, tissue, organs and body parts; surgical, medical, and veterinary apparatus, devices, and instruments for use in implanting regenerative cells into humans and animals to treat damaged and diseased skin, tissue, organs and body parts; surgical, medical, and veterinary apparatus, devices, and instruments for use in cell therapy and regenerative medicine; medical and veterinary devices, namely, applicators to implant regenerative cells into humans and animals for the treatment of damaged and diseased skin, tissue, organs and body parts; sample preparation devices for medical diagnostic use; apparatus for the regeneration of stem cells for medical purposes; component parts and fittings for all of the aforesaid
Pharmaceutical preparations for the treatment of diseased skin, tissue, organs and body parts in the nature of treatment for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; veterinary pharmaceutical preparations for the treatment of diseased skin, tissue, organs and body parts in the nature of treatment for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; pharmaceutical preparations and substances for the treatment of damaged skin and tissue, namely, tissue regenerative pharmaceutical preparations; cellular medicines, namely, stem cells for medical or veterinary use; reagents for medical or veterinary use; clinical medical and veterinary reagents; medical and veterinary diagnostic reagents; reagents for medical and veterinary diagnosis and medical and veterinary diagnostic research; chemical reagents for testing aqueous solutions for medical and veterinary purposes; reagents for use in biological processing for medical and veterinary purposes; media for biological and bacteriological cultures for medical and veterinary use; non-aqueous solvents for use in tests for medical and veterinary purposes; aqueous solutions for use in tests for medical and veterinary purposes; non-aqueous culture media for medical and veterinary use; chemicals preparations, namely, buffer solutions for use in tests for medical and veterinary purposes; chemicals, namely, surfactants for use in tests for medical and veterinary purposes
No 79223494
No Service/Collective Mark
No 221834-00019
No
No
No
No
Yes
Yes
No
No
| Status Date | Action Taken |
|---|---|
| 25th Dec 2023 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 04th Dec 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| 25th Oct 2019 | NEW REPRESENTATIVE AT IB RECEIVED |
| 26th Apr 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 05th Apr 2019 | FINAL DISPOSITION PROCESSED |
| 05th Apr 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| 25th Mar 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 25th Dec 2018 | REGISTERED-PRINCIPAL REGISTER |
| 09th Oct 2018 | PUBLISHED FOR OPPOSITION |
| 09th Oct 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
